Financial News
Latest News about Raghuram Selvaraju
Recent news which mentions Raghuram Selvaraju
Inovio Analyst Says Thermo Fisher Deal 'One Solid Step' Toward COVID-19 Vaccine Commercialization
September 09, 2020
From Benzinga
From Benzinga
Sorrento Therapeutics Analyst Says Coronavirus Antibody Cocktail One Of Few Non-Vaccine Options
May 18, 2020
Tickers
SRNE
From Benzinga
Inovio Analysts Project About 24% Upside Potential Amid Optimism On Coronavirus DNA Vaccine
April 29, 2020
Tickers
INO
From Benzinga
Biotech Stock On The Radar: Immunomedics' Long Wait For Redemption
October 23, 2019
From Benzinga
Movers And Shakers At ESMO 2019: Immunomedics, G1 Therapeutics, Seattle Genetics And More
September 30, 2019
From Benzinga
HC Wainwright Says Aerpio Pharma Flies Under The Radar Due To OTC Listing, Projects 150% Upside
April 21, 2018
From Benzinga
From Benzinga
HTG Molecular's Deal With Merck KGaA 'Provides Further Validation' For EdgeSeq Technology
December 27, 2017
From Benzinga
What You Should Know About The Drug Approval Valeant Could Receive This Week
September 18, 2017
From Benzinga
From Benzinga
An 'Unsung Potential Winner,' ObsEva Initiated At Buy
June 29, 2017
From Benzinga
FDA Removes Clinical Hold On Inovio Pharma's VGX-3100, Its First Drug To Enter A Pivotal Study
June 08, 2017
From Benzinga
From Benzinga
From Benzinga
What Synergy's New Patents Mean For Its Commercial Prospects
April 17, 2017
From Benzinga
From Benzinga
Synergy's Safety Profile Should Boost Trulance Uptake, Takeover Prospects Remain Favorable
March 02, 2017
From Benzinga
Synergy Pharma's Plecanitide Finally Crosses The Finish Line; Rodman & Renshaw Lifts Price Target To $18
January 20, 2017
From Benzinga
Synergy Hits Endpoints, Earns A Price Target Bump At Rodman & Renshaw
December 23, 2016
From Benzinga
From Benzinga
Rodman & Renshaw Prescribe A $6 Price Target For Cancer Genetics
September 26, 2016
Tickers
CGIX
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
